poisar

Stocks · News reference

Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $250

Aug 12, 2026, 1:50 PMBenzinga Newsdesk

Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $240 to $250.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

CAH
Source
benzinga
Observed
Aug 12, 2026, 1:50 PM
Checked
Aug 12, 2026, 1:50 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 23, 2026, 11:31 AMJonathan Ponciano

    Cardinal Health's CFO Moved $9.9 Million of Stock. Here's What Long-Term Investors Should Know

    Cardinal Health's CFO Aaron Alt sold 42,000 shares worth $9.9 million on August 18, reducing his direct holdings to 20,495 shares. The sale occurred after the stock surged 57% over the past year. Despite the insider sale, the company maintains strong guidance with fiscal 2027 EPS projected at $12.40-$12.60 (13-15% growth), planned capital expenditures of $700 million, and at least $1 billion in share repurchases expected.

    Read original at the-motley-fool
    CAH